Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Allakos Inc.
DescriptionUndisclosed antibody that induces the killing of mast cells and eosinophils
Molecular Target Undisclosed
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Hematology (unspecified)
Indication DetailsTreat indolent systemic mastocytosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today